Showing 1 - 5 results of 5 for search 'Luisa I Alvarado', query time: 0.03s Refine Results
  1. 1
    Reduced spread of influenza and other respiratory viral infections during the COVID-19 pandemic in southern Puerto Rico.

    Reduced spread of influenza and other respiratory viral infections during the COVID-19 pandemic in southern Puerto Rico. by Talia M Quandelacy, Laura E Adams, Jorge Munoz, Gilberto A Santiago, Sarah Kada, Michael A Johansson, Luisa I Alvarado, Vanessa Rivera-Amill, Gabriela Paz-Bailey

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoprotein.

    Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of... by John M Powers, Zoe L Lyski, Whitney C Weber, Michael Denton, Magdalene M Streblow, Adam T Mayo, Nicole N Haese, Chad D Nix, Rachel Rodríguez-Santiago, Luisa I Alvarado, Vanessa Rivera-Amill, William B Messer, Daniel N Streblow

    Published 2023-03-01
    Get full text
    Article
  3. 3
    Associations between the social environment and early childhood developmental outcomes of Puerto Rican children with prenatal Zika virus exposure: a cross-sectional study

    Associations between the social environment and early childhood developmental outcomes of Puerto Rican children with prenatal Zika virus exposure: a cross-sectional study by Mary Rodríguez-Rabassa, Allison A. Appleton, Viviana Rosario-Villafañe, Irelis Repollet-Carrer, Marilyn Borges-Rodríguez, Lydiet Dedós-Peña, Marielly González, Paola Velázquez-González, Kamalich Muniz-Rodriguez, Claudia Mántaras-Ortiz, Vanessa Rivera-Amill, Odette Olivieri-Ramos, Luisa I. Alvarado-Domenech

    Published 2024-05-01
    Get full text
    Article
  4. 4
    The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ<sup>®</sup>) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection

    The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ<sup>®</sup>) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to... by Whitney C. Weber, Zachary J. Streblow, Craig N. Kreklywich, Michael Denton, Gauthami Sulgey, Magdalene M. Streblow, Dorca Marcano, Paola N. Flores, Rachel M. Rodriguez-Santiago, Luisa I. Alvarado, Vanessa Rivera-Amill, William B. Messer, Romana Hochreiter, Karin Kosulin, Katrin Dubischar, Vera Buerger, Daniel N. Streblow

    Published 2024-08-01
    Get full text
    Article
  5. 5
    Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012-2015.

    Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012-2015. by Kay M Tomashek, Olga D Lorenzi, Doris A Andújar-Pérez, Brenda C Torres-Velásquez, Elizabeth A Hunsperger, Jorge Luis Munoz-Jordan, Janice Perez-Padilla, Aidsa Rivera, Gladys E Gonzalez-Zeno, Tyler M Sharp, Renee L Galloway, Mindy Glass Elrod, Demetrius L Mathis, M Steven Oberste, W Allan Nix, Elizabeth Henderson, Jennifer McQuiston, Joseph Singleton, Cecilia Kato, Carlos García Gubern, William Santiago-Rivera, Jesús Cruz-Correa, Robert Muns-Sosa, Juan D Ortiz-Rivera, Gerson Jiménez, Ivonne E Galarza, Kalanthe Horiuchi, Harold S Margolis, Luisa I Alvarado

    Published 2017-09-01
    Get full text
    Article

Search Tools: